Brand Post Enlivex Announces Dosing of the First Patient in Phase I/II Trial Evaluating… GlobeNewswire Nov 15, 2022
Brand Post Mullen ‘Strikingly Different’ EV Crossover Tour Heads to Texas After Completing a… GlobeNewswire Nov 15, 2022
